• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency.

作者信息

Martí Ramon, Nishigaki Yutaka, Hirano Michio

机构信息

Department of Neurology, Columbia University College of Physicians and Surgeons, P&S 4-443, 630 West 168th Street, New York, NY 10032, USA.

出版信息

Biochem Biophys Res Commun. 2003 Mar 28;303(1):14-8. doi: 10.1016/s0006-291x(03)00294-8.

DOI:10.1016/s0006-291x(03)00294-8
PMID:12646159
Abstract

Mutations in the nuclear gene encoding thymidine phosphorylase (TP) cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), an autosomal recessive disease with mitochondrial dysfunction and mitochondrial DNA abnormalities. We have demonstrated alterations of thymidine (dThd) metabolism in MNGIE patients. Here, we report the accumulation of another substrate of TP, deoxyuridine (dUrd), whose circulating levels ranged from 5.5 to 24.4 microM (average 14.2) in MNGIE and were undetectable (<0.05 microM) in both TP mutation carriers and controls. The dramatic accumulation of dUrd may contribute to nucleotide pool imbalances and, together with the increased levels of dThd, is likely to contribute to the pathogenesis of MNGIE.

摘要

相似文献

1
Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency.
Biochem Biophys Res Commun. 2003 Mar 28;303(1):14-8. doi: 10.1016/s0006-291x(03)00294-8.
2
Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.胸苷磷酸化酶缺乏症患者的位点特异性体细胞线粒体DNA点突变
J Clin Invest. 2003 Jun;111(12):1913-21. doi: 10.1172/JCI17828.
3
Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.通过生化检测对线粒体神经胃肠性脑肌病进行确诊。
Clin Chem. 2004 Jan;50(1):120-4. doi: 10.1373/clinchem.2003.026179. Epub 2003 Nov 18.
4
Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder.胸苷磷酸化酶缺乏会导致MNGIE:一种常染色体隐性线粒体疾病。
Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1217-25. doi: 10.1081/NCN-200027485.
5
Thymidine phosphorylase mutations cause instability of mitochondrial DNA.胸苷磷酸化酶突变会导致线粒体DNA不稳定。
Gene. 2005 Jul 18;354:152-6. doi: 10.1016/j.gene.2005.04.041.
6
Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity.胸苷磷酸化酶功能评估:血浆胸苷(和脱氧尿苷)及胸苷磷酸化酶活性的测定。
Methods Mol Biol. 2012;837:121-33. doi: 10.1007/978-1-61779-504-6_8.
7
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.线粒体神经胃肠性脑肌病(MNGIE):一种涉及两个基因组的疾病。
Neurologist. 2004 Jan;10(1):8-17. doi: 10.1097/01.nrl.0000106919.06469.04.
8
Infusion of platelets transiently reduces nucleoside overload in MNGIE.输注血小板可短暂减轻线粒体神经胃肠脑肌病(MNGIE)中的核苷过载。
Neurology. 2006 Oct 24;67(8):1461-3. doi: 10.1212/01.wnl.0000239824.95411.52. Epub 2006 Sep 13.
9
Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).胸苷和脱氧尿苷在线粒体神经胃肠性脑肌病(MNGIE)患者的组织中蓄积。
FEBS Lett. 2007 Jul 24;581(18):3410-4. doi: 10.1016/j.febslet.2007.06.042. Epub 2007 Jun 27.
10
Late-onset MNGIE due to partial loss of thymidine phosphorylase activity.由于胸苷磷酸化酶活性部分丧失导致的迟发性线粒体神经胃肠脑肌病。
Ann Neurol. 2005 Oct;58(4):649-52. doi: 10.1002/ana.20615.

引用本文的文献

1
High tide or low tide: the transport and metabolism of mitochondrial nucleotides.涨潮还是落潮:线粒体核苷酸的转运与代谢
Biochem J. 2025 Aug 18;482(16):BCJ20253237. doi: 10.1042/BCJ20253237.
2
Current advances in gene therapy of mitochondrial diseases.线粒体疾病的基因治疗新进展。
J Transl Med. 2022 Dec 5;20(1):562. doi: 10.1186/s12967-022-03685-0.
3
Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.胸苷磷酸化酶活性缺失破坏脂肪细胞分化并诱导胰岛素抵抗性脂肪萎缩性糖尿病。
BMC Med. 2022 Mar 28;20(1):95. doi: 10.1186/s12916-022-02296-2.
4
Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in and out of the liver'.线粒体肝病:呼吸链紊乱——肝脏的“呼吸”
World J Hepatol. 2021 Nov 27;13(11):1707-1726. doi: 10.4254/wjh.v13.i11.1707.
5
Plasma Metabolites Alert Patients With Chest Pain to Occurrence of Myocardial Infarction.血浆代谢物可警示胸痛患者心肌梗死的发生。
Front Cardiovasc Med. 2021 Apr 23;8:652746. doi: 10.3389/fcvm.2021.652746. eCollection 2021.
6
Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.线粒体神经胃肠性脑肌病:诊断与治疗方法
J Transl Genet Genom. 2020 Mar 30;4:1-16. doi: 10.20517/jtgg.2020.08.
7
Quantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy.采用液相色谱-串联质谱法对血浆和尿液中的胸苷和2'-脱氧尿苷进行定量分析,以评估线粒体神经胃肠性脑肌病患者红细胞包封的胸苷磷酸化酶的药效学。
J Clin Med. 2020 Mar 13;9(3):788. doi: 10.3390/jcm9030788.
8
Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial.红细胞包封的胸苷磷酸化酶治疗线粒体神经胃肠性脑肌病患者:一项多中心、多剂量、开放标签试验的研究方案
J Clin Med. 2019 Jul 24;8(8):1096. doi: 10.3390/jcm8081096.
9
Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy.红细胞包裹的胸苷磷酸化酶治疗线粒体神经胃肠脑肌病的安全性和有效性
J Clin Med. 2019 Apr 5;8(4):457. doi: 10.3390/jcm8040457.
10
Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy.α-1-抗胰蛋白酶启动子增强腺相关病毒载体治疗线粒体神经胃肠脑肌病的疗效。
Hum Gene Ther. 2019 Aug;30(8):985-998. doi: 10.1089/hum.2018.217. Epub 2019 Apr 24.